P-08 - ASSOCIATIONS BETWEEN ANTIDEPRESSANT PRESCRIBING AND ANTIBIOTIC RESISTANCE IN ESCHERICHIA COLI URINARY TRACT INFECTIONS IN SCOTLAND
Journal of Public Health · 09.07.2026 · 48 (Supplement_1) · i41-i42
DOI: 10.1093/pubmed/fdag046.079 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Public Health, online erschienen am 09.07.2026. Verfasst von Dr Laura Ciaccio und 11 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Preclinical evidence demonstrates that antidepressant drugs possess antibiotic properties that can induce antibiotic resistance, but no population-based studies have examined effects in clinical infections. This could have important implications for prescribing guidelines and patient care.
Objectives
This study examined associations between antidepressants and antibiotic resistance in Escherichia coli (E. coli) urinary tract infections (UTIs) in Scotland.
Methods
E. coli urinary isolates in Tayside (population=414,000), Scotland from individuals ≥16 years old from January 2019 to December 2023 were included. E. coli UTI episodes were linked to demography, healthcare, and community prescribing data. Univariate and multivariable logistic regression assessed associations between antidepressant use in the year prior to UTI and the odds of resistant and multidrug resistant (MDR) E. coli isolates. Covariates included age; sex; deprivation (Scottish Index of Multiple Deprivation quintile); comorbidity (Elixhauser unweighted score); infection source (community or hospital); year of episode; catheter use; number of hospital admissions; previous E. coli UTI; previous urinary procedure; and prescriptions for proton pump inhibitors (PPIs), beta-blockers, statins, and relevant antibiotics.
Results
There were 60,187 E. coli UTI episodes (in 30,887 individuals) during the study period. Antidepressants were recorded in 37.6% of episodes (n=22,061). MDR rates were higher in episodes in people with antidepressant prescriptions compared to those without (39.0% vs. 34.5%). In multivariable analysis, antidepressants increased the odds of any resistance (Adjusted OR 1.07 [95%CI1.03-1.11]) and MDR (Adjusted OR 1.10 [95%CI 1.06-1.15]). Other factors associated with increased odds of MDR in multivariable analysis included certain age groups; male sex; increased comorbidity; hospital-acquired infections; catheter use; prior hospital admissions; prior UTI; PPIs; and prior antibiotic prescriptions.
Conclusions
Antidepressants are associated with statistically significant increased odds of antibiotic resistance in E.coli UTI episodes. Targeted antibiotic prescribing, urine sample submission, and minimising unnecessary antibiotic exposure may be important for people prescribed antidepressants.
Zitieren
APA
Ciaccio, D. L., Parcell, D. B., Wang, D. H., Bhattacharjee, D. A., Danial, J., Kerr, F., McEwen, J., Morrison, A., O'Driscoll, D., Seaton, A., Marwick, D. C., & Barnett, D. K. (2026). P-08 - ASSOCIATIONS BETWEEN ANTIDEPRESSANT PRESCRIBING AND ANTIBIOTIC RESISTANCE IN ESCHERICHIA COLI URINARY TRACT INFECTIONS IN SCOTLAND. Journal of Public Health, 48(Supplement_1), i41-i42. https://doi.org/10.1093/pubmed/fdag046.079
Vancouver
Ciaccio DL, Parcell DB, Wang DH, Bhattacharjee DA, Danial J, Kerr F, et al. P-08 - ASSOCIATIONS BETWEEN ANTIDEPRESSANT PRESCRIBING AND ANTIBIOTIC RESISTANCE IN ESCHERICHIA COLI URINARY TRACT INFECTIONS IN SCOTLAND. Journal of Public Health. 2026;48(Supplement_1):i41-i42. doi:10.1093/pubmed/fdag046.079
BibTeX
@article{Ciaccio2026,
author = {Ciaccio, Dr Laura and Parcell, Dr Benjamin and Wang, Dr Huan and Bhattacharjee, Dr Atanu and Danial, Janathan and Kerr, Frances and McEwen, Jo and Morrison, Aidan and O'Driscoll, Deirdre and Seaton, Andrew and Marwick, Dr Charis and Barnett, Dr Karen},
title = {P-08 - ASSOCIATIONS BETWEEN ANTIDEPRESSANT PRESCRIBING AND ANTIBIOTIC RESISTANCE IN ESCHERICHIA COLI URINARY TRACT INFECTIONS IN SCOTLAND},
journal = {Journal of Public Health},
year = {2026},
volume = {48},
number = {Supplement_1},
pages = {i41--i42},
doi = {10.1093/pubmed/fdag046.079}
}
EUVIMED